The ClinGen Evidence Repository is an FDA-recognized human genetic variant database containing expert-curated assertions regarding variants' pathogenicity and supporting evidence summaries. [Disclaimer]
  • Gene obtained from curated document aligns with the Allele Registry but not with ClinVar data
  • No CSPEC computer assertion could be determined for this classification!


Variant: NM_001754.5(RUNX1):c.1085C>T (p.Ser362Leu)

CA410148181

2008544 (ClinVar)

Gene: RUNX1 (HGNC:861)
Condition: hereditary thrombocytopenia and hematologic cancer predisposition syndrome (MONDO:0011071)
Inheritance Mode: Autosomal dominant inheritance
UUID: aa730b3a-a6ad-408c-b234-a7d923af2179
Approved on: 2024-08-01
Published on: 2024-08-01

HGVS expressions

NM_001754.5:c.1085C>T
NM_001754.5(RUNX1):c.1085C>T (p.Ser362Leu)
NC_000021.9:g.34792493G>A
CM000683.2:g.34792493G>A
NC_000021.8:g.36164790G>A
CM000683.1:g.36164790G>A
NC_000021.7:g.35086660G>A
NG_011402.2:g.1197219C>T
ENST00000675419.1:c.1085C>T
ENST00000300305.7:c.1085C>T
ENST00000344691.8:c.1004C>T
ENST00000399240.5:c.812C>T
ENST00000437180.5:c.1085C>T
ENST00000482318.5:c.*675C>T
NM_001001890.2:c.1004C>T
NM_001754.4:c.1085C>T
NM_001001890.3:c.1004C>T
More

Uncertain Significance

Met criteria codes 2
BP4 PM2_Supporting
Not Met criteria codes 13
BA1 BS3 BS1 BP2 PVS1 BP7 PS2 PS4 PS3 PP3 PM1 PM4 PM6

Evidence Links 0

Expert Panel

Criteria Specification Information

Criteria Specification: ClinGen Myeloid Malignancy Expert Panel Specifications to the ACMG/AMP Variant Interpretation Guidelines Version 2

PDF
Criteria Specification Approval History
Criteria Specifications for this VCEP
Evidence submitted by expert panel
Myeloid Malignancy VCEP
NM_001754.5(RUNX1):c.1085C>T (p.Ser362Leu) is a missense variant which has a REVEL score <0.50 (0.223) (BP4). This variant is completely absent from all population databases (gnomAD v2.1.1 and v3.1.2) with at least 20x coverage for RUNX1 (PM2_supporting). In summary, the clinical significance of this variant is uncertain. ACMG/AMP criteria applied, as specified by the Myeloid Malignancy Variant Curation Expert Panel for RUNX1: BP4, PM2_supporting.
Met criteria codes
BP4
This missense variant has a REVEL score <0.50 (0.223) (BP4).
PM2_Supporting
This variant is completely absent from all population databases with at least 20x coverage for RUNX1 (PM2_supporting).
Not Met criteria codes
BA1
This rule cannot be applied since the variant is completely absent from all population databases.
BS3
To our knowledge, no in vitro or in vivo functional studies are available for this variant.
BS1
This rule cannot be applied since the variant is completely absent from all population databases.
BP2
This rule cannot be applied since, to our knowledge, this variant has not been reported in any study.
PVS1
This rule cannot be applied since this is a missense variant.
BP7
This rule cannot be applied since this is a missense variant.
PS2
This rule cannot be applied since, to our knowledge, this variant has not been reported in any study.
PS4
This rule cannot be applied since, to our knowledge, this variant has not been reported in any study.
PS3
To our knowledge, no in vitro or in vivo functional studies are available for this variant.
PP3
This rule cannot be applied since this missense variant has not a REVEL score >0.88 (0.223).
PM1
This rule cannot be applied since this missense variant affects amino acid residue 362, which is out of RHD or residues 89-204.
PM4
This rule cannot be applied since the variant is a missense change.
PM6
This rule cannot be applied since, to our knowledge, this variant has not been reported in any study.
Curation History
The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. If you have questions about the information contained on this website, please see a health care professional.
ClinGen Terms of Use.
¤ Powered by BCM's Genboree.